NYSE Euronext accueille Eli Lilly and Company, déjà cotée sur le NYSE, sur son marché européen

Back

New York/Paris, 25 March 2013 – NYSE Euronext announced that international pharmaceutical company Eli Lilly and Company (ticker: LLY), based in Indianapolis, Indiana (USA), completed its listing on NYSE Euronext Paris today. Eli Lilly and Company is the seventeenth company already listed in the United States to join the European platform since the streamlined, cost-effective Fast Path process was adopted. On 27 February 2013, the company announced its decision to delist from the London Stock Exchange on 27 March this year.Eli Lilly and Company maintains its principal listing on the New York Stock Exchange.

Eli Lilly and Company is an innovation-driven company that discovers, develops, manufactures, and markets products in two business segments – human pharmaceutical products and animal health products. It employs more than 38,000 people worldwide and sells its products in approximately 130 countries.

Eli Lilly and Company was listed on NYSE Euronext Paris through the admission to trading of the 1.1 billion shares making up the company’s capital stock, representing a total market capitalisation of approximately EUR 48.6 billion / USD 62.9 billion.

“We are delighted to welcome Eli Lilly and Company to our European market and in so doing promote biotechnology as a cutting-edge industry and priority ”said Diederik Zandstra, Head of the European Corporate Client Group at NYSE Euronext.

Press Release Footer

About Euronext 
Euronext is the leading European capital market infrastructure, covering the entire capital markets value chain, from listing, trading, clearing, settlement and custody, to solutions for issuers and investors. Euronext runs MTS, one of Europe’s leading electronic fixed income trading markets, and Nord Pool, the European power market. Euronext also provides clearing and settlement services through Euronext Clearing and its Euronext Securities CSDs in Denmark, Italy, Norway and Portugal.
As of September 2025, Euronext’s regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal host over 1,700 listed issuers with €6.5 trillion in market capitalisation, a strong blue-chip franchise and the largest global centre for debt and fund listings. With a diverse domestic and international client base, Euronext handles 25% of European lit equity trading. Its products include equities, FX, ETFs, bonds, derivatives, commodities and indices.
In November 2025, Euronext successfully acquired a majority stake in the Athens Stock Exchange (ATHEX), further expanding its footprint and strengthening its pan-European market infrastructure.

For the latest news and resources, please visit the Media Centre. 
Follow us on X (x.com/euronext) and LinkedIn (linkedin.com/company/euronext).

Disclaimer
This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2025, Euronext N.V. - All rights reserved.